This programme is organised and funded by PTC Therapeutics, Inc. for healthcare professionals only.
Product-related information will be discussed.
LIVE WEBINAR

REGISTER NOW to join Professors Tracey Willis and Thomas Sejersen for a live webinar discussing the DMD disease continuum

Days
Hours
Minutes
Seconds
For more information on the session, keep scrolling.
Faculty
Professor Tracey Willis

Professor Tracey Willis

Neuromuscular Specialist, Robert Jones and Agnes Hunt Hospital, Oswestry, UK
Professor Thomas Sejersen

Professor Thomas Sejersen

Professor in Neuropediatrics, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

In recent years, multidisciplinary care of Duchenne muscular dystrophy (DMD) has evolved. Advances in assessments, interventions, and emerging genetic and molecular therapies have led to improved patient survival, as well as renewed focus on patient quality of life.1

What challenges do you experience in the long-term management of your patients and their transition from paediatric to adult care?

We invite you to join our live webinar, The DMD Continuum: From early intervention to adult care transition, on Thursday 30 September at 18:00 CEST (for other time zones, please click here).

Hear from Professors Tracey Willis and Thomas Sejersen as they explore best practice management of DMD in light of recent diagnostic and therapeutic advances. Using patient cases and clinical data, they will address approaches to delaying milestones that may slow disease progression, preserve function and improve patient outcomes. Register now to save your seat and join the discussion.

Professor Tracey Willis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Professor Thomas Sejersen

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Registration form

  • This webinar is intended for healthcare professionals only (the “Webinar”), and is operated by PTC Therapeutics, Inc. (together with its affiliates “PTC”). In order to access this webinar:

  • PTC will retain your information for a limited period of time following your registration, according to PTC’s internal guidelines. Providing your personal data and your consent is voluntary; you have the right to withdraw your consent at any time, without giving any reasons. Click here to view our Privacy Statement.

    For any enquiry relating to the processing of your personal data or if you want to exercise your privacy related rights or withdraw your consent, you can contact PTC’s Privacy Office at: Dataprivacy@ptcbio.com.

    You can unsubscribe from this updates service at any time when receiving an email from PTC.

Professor Tracey Willis

Professor Tracey Willis

Neuromuscular Specialist, Robert Jones and Agnes Hunt Hospital, Oswestry, UK

Professor Thomas Sejersen

Professor Thomas Sejersen

Professor in Neuropediatrics, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

Professor Tracey Willis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Professor Thomas Sejersen

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Don’t forget to register now to hear the latest approaches to best practice in DMD care to help delay disease progression

Reference:

  1. Birnkrant DJ, Bushby K, Bann CM, et al. Lancet Neurol 2018;17(3):251–267.